Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM

Salah-Eddin Al-Batran; Ralf Dieter Hofheinz; Harald Schmalenberg; Dirk Strumberg; Eray Goekkurt; Stefan Angermeier; Thomas Zander; Jochem Potenberg; Hans Georg Kopp; Daniel Pink; Gabriele Margareta Siegler; Michael Schenk; Ferdinando De Vita; Evaristo Maiello; Timo Gaiser; Disorn Sookthai; Ulli Simone Bankstahl; Claudia Pauligk; Thorsten Oliver Goetze; Nils Homann

Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM

Salah-Eddin Al-Batran
, Ralf Dieter Hofheinz
, Harald Schmalenberg
, Dirk Strumberg
, Eray Goekkurt
, Stefan Angermeier
, Thomas Zander
, Jochem Potenberg
, Hans Georg Kopp
, Daniel Pink
, Gabriele Margareta Siegler
, Michael Schenk
, Ferdinando De Vita
, Evaristo Maiello
, Timo Gaiser
, Disorn Sookthai
, Ulli Simone Bankstahl
, Claudia Pauligk
, Thorsten Oliver Goetze
, Nils Homann

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

22 Citations (Web of Science)

Original language	Undefined/Unknown
Journal	Journal of Clinical Oncology
Publication status	Published - 2020

Cite this

Al-Batran, S.-E., Hofheinz, R. D., Schmalenberg, H., Strumberg, D., Goekkurt, E., Angermeier, S., Zander, T., Potenberg, J., Kopp, H. G., Pink, D., Siegler, G. M., Schenk, M., De Vita, F., Maiello, E., Gaiser, T., Sookthai, D., Bankstahl, U. S., Pauligk, C., Goetze, T. O., & Homann, N. (2020). Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM. Journal of Clinical Oncology.

@article{caec3b2509a64d5d9fab795b24be80c4,

title = "Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM",

author = "Salah-Eddin Al-Batran and Hofheinz, \{Ralf Dieter\} and Harald Schmalenberg and Dirk Strumberg and Eray Goekkurt and Stefan Angermeier and Thomas Zander and Jochem Potenberg and Kopp, \{Hans Georg\} and Daniel Pink and Siegler, \{Gabriele Margareta\} and Michael Schenk and \{De Vita\}, Ferdinando and Evaristo Maiello and Timo Gaiser and Disorn Sookthai and Bankstahl, \{Ulli Simone\} and Claudia Pauligk and Goetze, \{Thorsten Oliver\} and Nils Homann",

year = "2020",

language = "Undefined/Unknown",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins ",

}

Al-Batran, S-E, Hofheinz, RD, Schmalenberg, H, Strumberg, D, Goekkurt, E, Angermeier, S, Zander, T, Potenberg, J, Kopp, HG, Pink, D, Siegler, GM, Schenk, M, De Vita, F, Maiello, E, Gaiser, T, Sookthai, D, Bankstahl, US, Pauligk, C, Goetze, TO & Homann, N 2020, 'Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM', Journal of Clinical Oncology.

Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM. / Al-Batran, Salah-Eddin; Hofheinz, Ralf Dieter; Schmalenberg, Harald et al.
In: Journal of Clinical Oncology, 2020.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM

AU - Al-Batran, Salah-Eddin

AU - Hofheinz, Ralf Dieter

AU - Schmalenberg, Harald

AU - Strumberg, Dirk

AU - Goekkurt, Eray

AU - Angermeier, Stefan

AU - Zander, Thomas

AU - Potenberg, Jochem

AU - Kopp, Hans Georg

AU - Pink, Daniel

AU - Siegler, Gabriele Margareta

AU - Schenk, Michael

AU - De Vita, Ferdinando

AU - Maiello, Evaristo

AU - Gaiser, Timo

AU - Sookthai, Disorn

AU - Bankstahl, Ulli Simone

AU - Pauligk, Claudia

AU - Goetze, Thorsten Oliver

AU - Homann, Nils

PY - 2020

Y1 - 2020

UR - https://publons.com/wos-op/publon/35235609/

M3 - Original Article

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion-A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM

Other files and links

Cite this